Skip to main content

Table 2 Clinical characteristics of the patient in the present study

From: Comparison of various risk scores for the prognosis of hemorrhagic upper gastrointestinal mucosal disorder

   

Total

Survival

Death

p value

Characteristic

Sex (%)

Male/Female

195 (73)/70 (26.4)

185 (74)/65 (26)

10 (66.7)/5 (33.3)

0.551

Age (mean ± SD)

 

71.2 ± 12.7

71.1 ± 12.7

73.3 ± 12.2

0.509

Drug

Aspirin (%)

 

118 (44.9)

111 (44.8)

7 (46.7)

0.131

Aspirin + Clopidogrel (%)

 

45 (17.1)

44 (17.7)

1 (6.7)

0.479

Anticoagulant drugs (%)

 

72 (27.4)

65 (26.2)

7 (46.7)

0.131

Other antiplatelet drugs (%)

 

10 (3.8)

10 (4.0)

0 (0.0)

> 0.999

NSAIDs (%)

 

53 (20.1)

50 (20.1)

3 (20.0)

> 0.999

Preventive drugs (%)

H2RA/PPI/MPAs

31 (11.7)/51 (19.2)/21 (7.9)

30 (12.0)/46 (18.4)/19 (7.6)

1 (6.7)/5 (33.3)/2 (13.3)

0.047

  1. NSAIDs non-steroidal anti-inflammatory drugs, H2RA histamine H2 receptor antagonist, PPI proton pomp inhibitor, MPAs mucosal protective agents